What is Hemispheric?
Hemispheric operates at the intersection of neuroscience and artificial intelligence, specializing in the decoding of non-invasive brain activity. Its core technology, the Descartes model, is built upon one of the world's most extensive multimodal brain datasets. By translating raw neural signals into structured, actionable data, the company provides a foundational platform for precision brain health, medical device innovation, and pharmaceutical research. The firm's market position is defined by its ability to process high-dimensional neural information at scale, offering a unique value proposition to stakeholders in the healthcare and biotechnology sectors.
How much funding has Hemispheric raised?
Hemispheric has raised a total of $52M across 1 funding round:
Unspecified
$52M
Unspecified (2026): $52M with participation from Protocol Labs, One Mind, Hanaco, L Catterton, and Arkin Holdings
Key Investors in Hemispheric
Protocol Labs
Protocol Labs is a research, development, and deployment lab for network protocols that creates software systems to tackle significant technological challenges through open-source innovation.
One Mind
One Mind is a leading mental health non-profit that catalyzes comprehensive action across the brain health crisis, working to accelerate treatments and cures for mental disorders.
Hanaco
Hanaco Ventures is a venture capital firm focused on supporting founders with big ideas, emphasizing decisive action and collaboration with entrepreneurs at various growth stages.
What's next for Hemispheric?
With this latest injection of capital, Hemispheric is poised to accelerate the deployment of its Descartes model across broader clinical and commercial applications. The company's roadmap focuses on deepening its integration with CNS drug development pipelines and expanding its footprint in the brain-computer interface market. By prioritizing the refinement of its neural decoding algorithms, Hemispheric aims to solidify its role as an essential partner for organizations seeking to leverage brain data for therapeutic and diagnostic advancements. The firm's strategic trajectory suggests a transition toward long-term enterprise partnerships, further cementing its influence in the evolving landscape of digital health and neuro-technology.
See full Hemispheric company page
